英国癌症研究院2024年招聘博士后（放射-增强免疫疗法）

英国癌症研究院是英国的一所公立性质院校，位于英国伦敦。

Postdoctoral Training Fellow

The Institute of Cancer Research - Radiation-enhanced Immunotherapy

Salary: Dependent on relevant Postdoctoral experience. Future progression is based on annual performance review. If the candidate has not yet been awarded their PhD, the starting salary will be at £35,844 until the successful completion of their viva.

This role is eligible for ICR Sponsorship, subject to eligibility. Support will be provided for costs associated with Visa application. If you are considering relocating to the UK, further information can be found here.

Duration of Contract: Fixed Term until July 2026

Hours per week: 35 hours per week (Full Time)

Job Details

Under the leadership of Erik Wennerberg, we are seeking to appoint a Postdoctoral Training Fellow to join the Radiation-enhanced Immunotherapy Group to study how radiotherapy alters the tumour microenvironment in solid cancers, characterize radiation-induced immune checkpoints, focusing on perturbations of immunometabolic pathways, with the goal of developing treatment strategies that optimize the immunogenicity of radiotherapy-immunotherapy combinations.

General information on Post Doc's at The ICR can be found here.

Key Requirements

The successful candidate must have a PhD in Biological Sciences (or equivalent) and have knowledge of cancer biology and tumour immunology. Expertise in cancer metabolism is desirable but not essential. They need to be able to work independently while having excellent communication/collaboration skills to operate in a multidisciplinary research environment.

The ICR has a workforce agreement stating that Postdoctoral Training Fellows can only be employed for up to 7 years as PDTF at the ICR, providing total postdoctoral experience (including previous employment at this level elsewhere) does not exceed 10 years

Department/Directorate Information:

The Radiation-enhanced Immunotherapy Group is newly established at the ICR and we are dedicated to understanding how metabolic reprogramming contributes to immune resistance in developing tumours and how this process is affected by cancer therapy. Our goal is to identify and characterise therapy-induced immune checkpoints that we can target to optimise radiotherapy-immunotherapy treatments for patients with lung cancer and other solid tumours.

https://www.icr.ac.uk/our-research/research-divisions/radiotherapy-and-imaging/radiation-enhanced-immunotherapy

We are based in a dynamic and diverse research environment in the Division of Radiotherapy and Imaging in Sutton.

https://www.icr.ac.uk/our-research/research-divisions/radiotherapy-and-imaging

We are part of the wider Centre for Translational Immunotherapy (CTI), which brings together multidisciplinary immunology researchers across the ICR and the Royal Marsden Hospital.

Further, we are connected to a wide network of national and international collaborators, including our close collaborators at Albert Einstein School of Medicine, New York. Our lab has an active public engagement programme that is central to our research approach and an inspiring training environment for early career scientists including tailored courses to support scientific, personal, and wider career development.